Alpha 2.0
Login Register
» Articles » PMID: 3918735

Dihydrocodeine in Renal Failure: Further Evidence for an Important Role of the Kidney in the Handling of Opioid Drugs

Overview
Journal Br Med J (Clin Res Ed)
Specialty General Medicine
Date 1985 Mar 9
PMID 3918735
Citations 10
Authors
J N Barnes
A J Williams
M J Tomson
P A Toseland
F J Goodwin
Affiliations
Soon will be listed here.
Abstract

The pharmacokinetics of a single oral dose of dihydrocodeine were studied in nine patients with chronic renal failure treated by haemodialysis and nine subjects with normal renal function. In the patients the mean peak plasma dihydrocodeine concentration occurred later and the area under the curve was greater than in the normal subjects. Furthermore, the drug was still detectable after 24 hours in all the patients but only three of the normal subjects. These data, together with those obtained from previously published clinical case reports, contradict the traditional view that the body's ability to cope with opioid drugs is not altered in renal failure.

Citing Articles

Population pharmacokinetics of telapristone (CDB-4124) and its active monodemethylated metabolite CDB-4453, with a mixture model for total clearance.

Morris D, Podolski J, Kirsch A, Wiehle R, Fleckenstein L AAPS J. 2011; 13(4):665-73.

PMID: 22028249 PMC: 3221841. DOI: 10.1208/s12248-011-9304-7.

An analysis of discharge drug prescribing amongst elderly patients with renal impairment.

Wong N, Jones H Postgrad Med J. 1998; 74(873):420-2.

PMID: 9799917 PMC: 2360983. DOI: 10.1136/pgmj.74.873.420.

Pain treatment in multimorbid patients, the older population and other high-risk groups. The clinical challenge of reducing toxicity.

Wilder-Smith C Drug Saf. 1998; 18(6):457-72.

PMID: 9638390 DOI: 10.2165/00002018-199818060-00006.

Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity.

Matzke G, Frye R Drug Saf. 1997; 16(3):205-31.

PMID: 9098657 DOI: 10.2165/00002018-199716030-00005.

Principles of drug administration in renal insufficiency.

Lam Y, Banerji S, Hatfield C, Talbert R Clin Pharmacokinet. 1997; 32(1):30-57.

PMID: 9012555 DOI: 10.2165/00003088-199732010-00002.

References
1.
HUG Jr C, MELLETT L, Cafruny E . Stop-flow analysis of the renal excretion of tritium-labeled dihydromorphine. J Pharmacol Exp Ther. 1965; 150(2):259-69. View
2.
Ventkateswaran P, Jeffers A, Hocken A . Gastric acid secretion in chronic renal failure. Br Med J. 1972; 4(5831):22-3. PMC: 1786162. DOI: 10.1136/bmj.4.5831.22. View
3.
DON H, Dieppa R, Taylor P . Narcotic analgesics in anuric patients. Anesthesiology. 1975; 42(6):745-7. DOI: 10.1097/00000542-197506000-00021. View
4.
Olsen G, Bennett W, Porter G . Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clin Pharmacol Ther. 1975; 17(6):677-84. DOI: 10.1002/cpt1975176677. View
5.
Bianchetti G, Graziani G, Brancaccio D, Morganti A, Leonetti G, Manfrin M . Pharmacokinetics and effects of propranolol in terminal uraemic patients and in patients undergoing regular dialysis treatment. Clin Pharmacokinet. 1976; 1(5):373-84. DOI: 10.2165/00003088-197601050-00004. View